Literature DB >> 27951413

Immunometabolic parameters in overweight dogs during weight loss with or without an exercise program.

A D Vitger1, B M Stallknecht2, J E Miles3, S L Hansen4, A Vegge5, C R Bjørnvad3.   

Abstract

The influence of physical activity on metabolic health in overweight dogs is unknown. This study was conducted to evaluate biomarkers of immunometabolic health in relation to changes in physical activity and adiposity. Client-owned overweight dogs participated in a 12-wk intervention based on caloric restriction combined with a training program (fitness and diet [FD] group, n = 8), or caloric restriction alone (diet-only [DO] group, n = 8). Physical activity was monitored by accelerometry. All dogs were fed the same diet and achieved similar weight loss. Fasting blood samples were collected before and after 6- and 12-wk intervention. Insulin resistance was evaluated from plasma insulin and C-peptide as well as homeostasis model assessment. Inflammation and dyslipidemia were evaluated from circulating leptin, adiponectin, C-reactive protein (CRP), monocyte chemoattractant factor-1 (MCP-1), interleukin-8 (IL-8), and cholesterol. Accelerometer counts in both groups were high compared with previous reports of physical activity in overweight dogs. No difference in blood parameters was evident between groups, evaluated by linear mixed-effects model (P > 0.05). Within the groups, the following changes were significant by t-test (P < 0.05): leptin decreased in both groups. Within the FD group, IL-8, MCP-1, and CRP decreased at 6 wk and IL-8 and cholesterol at 12 wk. Within the DO group, C-peptide and HOMA decreased at 6 wk and C-peptide at 12 wk. We conclude that, for both groups, weight loss resulted in minor indications of improved immunometabolic health, whereas this level of physical activity did not add further benefits.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Accelerometry; Canine; Cytokine; Insulin resistance; Obesity

Mesh:

Substances:

Year:  2016        PMID: 27951413     DOI: 10.1016/j.domaniend.2016.10.007

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  6 in total

1.  Canine Geriatric Syndrome: A Framework for Advancing Research in Veterinary Geroscience.

Authors:  Brennen A McKenzie; Frances L Chen; Margaret E Gruen; Natasha J Olby
Journal:  Front Vet Sci       Date:  2022-04-21

2.  Veterinary-prescribed physical activity promotes walking in healthy dogs and people.

Authors:  Colleen Duncan; Angela Carswell; Tracy Nelson; Dan J Graham; Felix M Duerr
Journal:  BMC Vet Res       Date:  2020-12-01       Impact factor: 2.741

3.  Metabolic variables of obese dogs with insulin resistance supplemented with yeast beta-glucan.

Authors:  Chayanne Silva Ferreira; Thiago Henrique Annibale Vendramini; Andressa Rodrigues Amaral; Mariana Fragoso Rentas; Mariane Ceschin Ernandes; Flavio Lopes da Silva; Patricia Massae Oba; Fernando de Oliveira Roberti Filho; Marcio Antonio Brunetto
Journal:  BMC Vet Res       Date:  2022-01-03       Impact factor: 2.741

4.  Analytical performance of a canine ELISA monocyte chemoattractant protein-1 assay for use in cats and evaluation of circulating levels in normal weight and obese cats.

Authors:  Kathrine Stenberg; Line Gensby; Signe Emilie Cremer; Michelle Møller Nielsen; Charlotte Reinhard Bjørnvad
Journal:  Acta Vet Scand       Date:  2022-09-05       Impact factor: 2.048

Review 5.  Obesity, inflammation, and cancer in dogs: Review and perspectives.

Authors:  Pedro H Marchi; Thiago H A Vendramini; Mariana P Perini; Rafael V A Zafalon; Andressa R Amaral; Vanessa A Ochamotto; Juliano C Da Silveira; Maria L Z Dagli; Marcio A Brunetto
Journal:  Front Vet Sci       Date:  2022-10-03

6.  Gut microbiota composition may relate to weight loss rate in obese pet dogs.

Authors:  Ida N Kieler; Shamrulazhar Shamzir Kamal; Anne D Vitger; Dennis S Nielsen; Charlotte Lauridsen; Charlotte R Bjornvad
Journal:  Vet Med Sci       Date:  2017-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.